About this episode
In this episode, Allen Page, DVM, PhD, joined us to discuss some of his research on the metabolic effects of various intra-articular corticosteroids, as well as how ertugliflozin may influence horses’ metabolic responses to these treatments. Page spoke about how differences among corticosteroids can inform veterinarians’ choices when selecting intra-articular agents, key considerations when using SGLT2 inhibitors in horses that require joint injections, the limitations of the current research, and more.This episode of Disease Du Jour is brought to you by Equithrive.GUESTS AND LINKS - EPISODE 178:Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)Guest: Allen Page, DVM, PhDPodcast Website: Disease Du JourThis episode of Disease Du Jour podcast is brought to you by Equithrive.Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)
